NOVAVAX INC Contracts & Agreements

Securities Subscription Agreement, dated May 10, 2024, by and between Novavax, Inc. and Sanofi Pasteur Inc (Filed With SEC on May 13, 2024)

Confidential Settlement Agreement and Release, dated March 21, 2024, between the Company and FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas,... (Filed With SEC on May 10, 2024)

Modification No. 19 to Undefinitized Project Agreement No. 1, dated September 19, 2023, between the Company and Advanced Technology International (Filed With SEC on May 10, 2024)

Modification No. 20 to Undefinitized Project Agreement No. 1, dated December 1, 2023, between the Company and Advanced Technology International (Filed With SEC on May 10, 2024)

Modification No. 21 to Undefinitized Project Agreement No. 1, dated February 6, 2024, between the Company and Advanced Technology International (Filed With SEC on May 10, 2024)

Description of the Company's Securities (Filed With SEC on February 28, 2024)

Consulting and Advisory Agreement between the Company and (Filed With SEC on February 28, 2024)

Offer letter to (Filed With SEC on February 28, 2024)

Employment Agreement between the Company and (Filed With SEC on February 28, 2024)

Offer Letter to Elaine OHara dated (Filed With SEC on February 28, 2024)

Employment Agreement between the Company and (Filed With SEC on February 28, 2024)

Offer Letter to (Filed With SEC on February 28, 2024)

Employment Agreement between the Company and (Filed With SEC on February 28, 2024)

Termination and Settlement Agreement, dated as of February 16, 2024, between the Company and Gavi Alliance (Filed With SEC on February 28, 2024)

Settlement Agreement and General Release, dated August 8, 2023, between the Company and SK bioscience Co., Ltd (Filed With SEC on November 9, 2023)

Modification No. 18 to Undefinitized Project Agreement No. 1, dated May 25, 2023, between the Company and Advanced Technology International (Filed With SEC on August 8, 2023)

Amendment No. 1 to Advanced Purchase Agreement, effective as of (Filed With SEC on August 8, 2023)

Amendment No. 2 to Advanced Purchase Agreement, effective as of (Filed With SEC on August 8, 2023)

Amendment No. 3 to Advanced Purchase Agreement, effective as of (Filed With SEC on August 8, 2023)

Amendment No. 4 to Advanced Purchase Agreement, effective as of June 30, 2023, between the Company and His Majesty the King in Right of Canada, as represented by the Minister of... (Filed With SEC on August 8, 2023)

Amendment No. 2 to Advanced Purchase Agreement, dated as of April 6, 2022, between the Company and the Commonwealth of Australia as Represented by the Department of Health (Filed With SEC on August 8, 2023)

Amendment No. 3 to Advanced Purchase Agreement, dated as of April 5, 2023, between the Company and the Commonwealth of Australia as Represented by the Department of Health (Filed With SEC on August 8, 2023)

Amendment No. 4 to Advanced Purchase Agreement, dated as of July 5, 2023, between the Company and the Commonwealth of Australia as Represented by the Department of Health (Filed With SEC on August 8, 2023)

Form of Non-Statutory Stock Option Award Agreement (Filed With SEC on August 8, 2023)

Form of Global Non-Statutory Stock Option Award Agreement granted under the Companys Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on August 8, 2023)

Form of Restricted Stock Unit Award Agreement (Non-Employee Director) granted under the Companys Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on August 8, 2023)

Form of Global Restricted Stock Unit Award Agreement granted under the Companys Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on August 8, 2023)

Securities Subscription Agreement, dated as of August 8, 2023, between Novavax, Inc. and SK bioscience Co., Ltd (Filed With SEC on August 8, 2023)

At Market Issuance Sales Agreement by and among Novavax, Inc., Jefferies LLC and B. Riley Securities, Inc., dated August 8, 2023 (Filed With SEC on August 8, 2023)

Modification No. 17 to Undefinitized Project Agreement No. 1, dated February 6, 2023, between the Company and Advanced Technology International (Filed With SEC on May 9, 2023)

Consulting and Advisory Agreement between the Company and Dr. Gregory M. Glenn, dated as of March 20, 2023 (Filed With SEC on May 9, 2023)

Description of the Company's Securities (Filed With SEC on February 28, 2023)

Employment Agreement between the Company and John C. Jacobs, dated as of January 5, 2023 (Filed With SEC on February 28, 2023)

Consulting and Advisory Agreement between the Company and Stanley C. Erck, dated as of January 5, 2023 (Filed With SEC on February 28, 2023)

Modification No. 03 to Base Agreement between the Company and Advanced Technology International, dated as of November 30, 2022 (Filed With SEC on February 28, 2023)

Novavax, Inc. 2023 Inducement Plan (Filed With SEC on January 9, 2023)

Form of Non-Statutory Stock Option Agreement under the Novavax, Inc. 2023 Inducement Plan (Filed With SEC on January 9, 2023)

Form of Restricted Stock Unit Award Agreement under the Novavax, Inc. 2023 Inducement Plan (Filed With SEC on January 9, 2023)

Indenture, dated as of December 20, 2022, between Novavax, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on December 21, 2022)

Underwriting Agreement, dated as of December 15, 2022, between Novavax, Inc. and J.P. Morgan Securities LLC, Jefferies LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on December 19, 2022)

Amended and Restated SARS-CoV-2 Vaccine Supply Agreement, dated as of July 1, 2022, between the Company and The Secretary of State for Business, Energy, and Industrial Strategy,... (Filed With SEC on November 9, 2022)

Letter of Amendment to the Amended and Restated SARS-CoV-2 Vaccine Supply Agreement, dated as of September 26, 2022, between the Company and The Secretary of State for Business,... (Filed With SEC on November 9, 2022)

Modification No. 02 to Base Agreement between the Company and Advanced Technology International, dated as of August 2, 2022 (Filed With SEC on November 9, 2022)

Modification No (Filed With SEC on November 9, 2022)

Amendment of Solicitation/Modification of Contract No. 4, dated as of July 29, 2022, between the Company. and the U.S. Department of Defense Joint Program Executive Office for... (Filed With SEC on November 9, 2022)

Settlement Agreement, dated September 30, 2022, between the Company and FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas, LLC, and FUJIFILM... (Filed With SEC on November 9, 2022)

Contract Development Manufacture Agreement (Filed With SEC on August 9, 2022)

Amendment No. 1 to the Contract Development Manufacture Agreement (Filed With SEC on August 9, 2022)

Statement of Work No. 1 to the Contract Development Manufacture Agreement (Filed With SEC on August 9, 2022)

Modification No. 01 to Base Agreement between Novavax, Inc. and Advanced Technology International, dated as of March 23, 2022 (Filed With SEC on May 10, 2022)

Change Order No. 1 to the Collaboration and Exclusive License Agreement between Novavax, Inc. and SK Bioscience Company Limited, dated as of March 31, 2022 (Filed With SEC on May 10, 2022)

Description of (Filed With SEC on March 1, 2022)

Amendment to Deed of Lease for space at 700 Quince Orchard Road between ARE-MARYLAND NO. 51, LLC and the Company, dated June 22, 2021 (Filed With SEC on March 1, 2022)

Supply Agreement between the Company, Serum Institute of India Private Limited and Serum Life Sciences Limited, executed as of October 26, 2021 (Filed With SEC on March 1, 2022)

Amendment to Collaboration and Exclusive License Agreement between the Company and SK bioscience Company Limited, dated as of December 23, 2021 (Filed With SEC on March 1, 2022)

Statement of Work No. 1 to Collaboration and Exclusive License Agreement between the Company and SK bioscience Company Limited, dated as of December 23, 2021 (Filed With SEC on March 1, 2022)

Amendment to Advance Purchase Agreement between the Company, and the Commonwealth of Australia as represented by the Department of Health, dated as of December 23, 2021 (Filed With SEC on March 1, 2022)

Modification No. 12 to Undefinitized Project Agreement No. 01, dated December 20, 2021, between the Company and Advanced Technology International (Filed With SEC on March 1, 2022)

Modification No. 13 to Undefinitized Project Agreement No. 01, dated February 1, 2022, between the Company and Advanced Technology International (Filed With SEC on March 1, 2022)

Employment Agreement, dated July 12, 2021, between Novavax, Inc. and James P. Kelly (Filed With SEC on November 5, 2021)

Offer letter to James P. Kelly dated July (Filed With SEC on November 5, 2021)

Consulting Agreement, dated August 10, 2021, between Novavax, Inc. and Gregory F. Covino (Filed With SEC on November 5, 2021)

Amended and Restated Supply and License Agreement, dated July 1, 2021, between Novavax, Inc. and Serum Institute of India Private Limited (Filed With SEC on November 5, 2021)

Modification No. 09 to Undefinitized Project Agreement No. 1, dated July 16, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on November 5, 2021)

Modification No. 10 to Undefinitized Project Agreement No. 1, dated August 6, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on November 5, 2021)

Modification No. 11 to Undefinitized Project Agreement No. 1, dated August 26, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on November 5, 2021)

Advance Purchase Agreement, dated August 16, 2021, between Novavax, Inc., Novavax CZ and the European Commission (Filed With SEC on November 5, 2021)

Employment Agreement, dated April 12, 2021, between Novavax, Inc. and Gregory F. Covino (Filed With SEC on August 5, 2021)

Form of Amendment to Employment Agreement, dated June 17, 2021, between Novavax, Inc. and each of Stanley C. Erck, Gregory M. Glenn, John J. Trizzino and John A. Herrmann, III (Filed With SEC on August 5, 2021)

Novavax, Inc. Amended and Restated Change in Control Severance Benefit Plan (Filed With SEC on August 5, 2021)

Advance Purchase Agreement, dated May 5, 2021, between Novavax, Inc. and the Gavi Alliance (Filed With SEC on August 5, 2021)

Modification No. 07 to Undefinitized Project Agreement No. 1, dated April 23, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on August 5, 2021)

Modification No. 08 to Undefinitized Project Agreement No. 1, dated June 4, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on August 5, 2021)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley Securities, Inc., dated June 15, 2021 (Filed With SEC on June 15, 2021)

Collaboration and Exclusive License Agreement between Novavax, Inc. and SK Bioscience Company Limited, dated as of February 12, 2021 (Filed With SEC on May 10, 2021)

Collaboration and Exclusive License Agreement between Novavax, Inc. and Takeda Pharmaceutical Company Limited, dated as of February 24, 2021 (Filed With SEC on May 10, 2021)

Description of Registrants Securities (Filed With SEC on March 1, 2021)

Employment Agreement between Novavax, Inc. and Gregory F. Covino dated October 30, 2020 (Filed With SEC on March 1, 2021)

Offer letter to Gregory F. Covino dated October 30, 2020 (Filed With SEC on March 1, 2021)

Deed of Lease for space at 700 Quince Orchard Road between ARE-MARYLAND NO. 51, LLC and Novavax, Inc., dated October 22, 2020 (Filed With SEC on March 1, 2021)

SARS-CoV-2 Vaccine Supply Agreement, effective as of October 22, 2020, between Novavax, Inc. and The Secretary of State for Business, Energy and Industrial Strategy, acting on... (Filed With SEC on March 1, 2021)

Advance Purchase Agreement, effective as of December 31, 2020, between Novavax, Inc. and the Commonwealth of Australia as represented by the Department of Health (Filed With SEC on March 1, 2021)

Advance Purchase Agreement, effective as of January 19, 2021, between Novavax, Inc. and Her Majesty the Queen in Right of Canada, as represented by the Minister of Public Works... (Filed With SEC on March 1, 2021)

Modification No. 02 to Undefinitized Project Agreement No. 01, entered into September 10, 2020, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 03 to Undefinitized Project Agreement No. 01, entered into September 18, 2020, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 04 to Undefinitized Project Agreement No. 01, entered into December 23, 2020, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 05 to Undefinitized Project Agreement No. 01, dated January 12, 2021, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 06 to Undefinitized Project Agreement No. 01, entered into January 19, 2021, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Amendment of Solicitation/Modification of Contract, Modification No. 2, entered into December 1, 2020, between the Company and the U.S. Department of Defense Joint Program... (Filed With SEC on March 1, 2021)

Amendment of Solicitation/Modification of Contract, Modification No. 3, entered into January 5, 2021, between the Company and the U.S. Department of Defense Joint Program... (Filed With SEC on March 1, 2021)

Amendment Number 1 to the iPDP and Budget of the Outbreak Response Funding Agreement (Step 2), entered into on November 2, 2020, between Novavax, Inc. and the Coalition for... (Filed With SEC on March 1, 2021)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley Securities, Inc., dated January 22, 2021 (Filed With SEC on January 22, 2021)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley Securities, Inc., dated November 10, 2020 (Filed With SEC on November 10, 2020)

Restated Funding Agreement, entered into on May 11, 2020, by and between the Company and the Coalition for Epidemic Preparedness Innovations (Filed With SEC on August 10, 2020)

Share Purchase Agreement, dated May 27, 2020, by and among the Company (solely as guarantor), Novavax AB, De Bilt Holdings B.V., Poonawalla Science Park B.V., Bilthoven... (Filed With SEC on August 10, 2020)

Letter Contract, entered into on June 8, 2020, by and between the Company and the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological... (Filed With SEC on August 10, 2020)

Form of Series A Convertible Preferred Stock Certificate (Filed With SEC on June 19, 2020)

Series A Convertible Preferred Subscription Agreement, dated as of June 15, 2020, by and between the Company and RA Capital Healthcare Fund, L.P (Filed With SEC on June 19, 2020)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated May 18, 2020 (Filed With SEC on May 18, 2020)

Amended and Restated 2013 Employee Stock Purchase Plan (Filed With SEC on May 11, 2020)

Description of Registrants Securities (Filed With SEC on March 11, 2020)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated March 2, 2020 (Filed With SEC on March 2, 2020)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated January 21, 2020 (Filed With SEC on January 21, 2020)

Form of Stock Appreciation Right Award Agreement granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on November 7, 2019)

Asset Purchase Agreement between Novavax, Inc. and Paragon Bioservices, Inc. dated June 26, 2019 (Filed With SEC on August 7, 2019)

Lease Extension for space at 9920 Belward Campus Drive between Novavax, Inc. and ARE-Maryland No. 46, LLC, dated April 26, 2019 (Filed With SEC on May 2, 2019)

Form of Restricted Stock Unit Agreement granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on March 18, 2019)

Fifth Amendment to Lease Agreement for space at 9920 Belward Campus Drive between ARE-MARYLAND NO. 46, LLC and Novavax, Inc., dated January 16, 2019 (Filed With SEC on March 18, 2019)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated December 31, 2018 (Filed With SEC on December 31, 2018)

Second Amended and Restated Joint Venture Agreement between Novavax, Inc. and Cadila Pharmaceuticals Limited, dated as of July 17, 2018 (Filed With SEC on November 7, 2018)

Second Amended and Restated Novavax Product License Agreement between Novavax, Inc. and CPL Biologicals Private Limited, dated as of July 17, 2018 (Filed With SEC on November 7, 2018)

Underwriting Agreement, dated April 11, 2018, by and among Novavax, Inc. and Citigroup Global Markets Inc. and Piper Jaffray & Co., as representatives of the several underwriters... (Filed With SEC on April 13, 2018)

At Market Issuance Sales Agreement between Novavax, Inc. and B. Riley FBR, Inc., dated December 29, 2017 (Filed With SEC on December 29, 2017)

First Amendment to Lease Agreement for space at 1201 Clopper Road between IP9 1201 Clopper Road , LLC and Novavax, Inc., dated August 23, 2017 (Filed With SEC on November 7, 2017)

Consulting Agreement between Novavax, Inc. and Barclay A. Phillips, effective November 9, 2017 (Filed With SEC on November 7, 2017)

FOURTH AMENDMENT TO LEASE (Filed With SEC on May 8, 2017)

SECOND AMENDMENT TO DEED OF LEASE (Filed With SEC on May 8, 2017)

NOVAVAX, INC. 2015 Stock Incentive Plan (Amended and Restated March 15, 2016) Incentive Stock Option Agreement (Filed With SEC on February 27, 2017)

NOVAVAX, INC. AMENDED AND RESTATED CHANGE IN CONTROLSEVERANCE BENEFIT PLAN Adopted by the Board of Directors August10, 2005 Amended by the Board of Directors July26, 2006 Amended... (Filed With SEC on February 27, 2017)

NOVAVAX,INC. Common Stock (parvalue $0.01 per share) AT MARKETISSUANCE SALES AGREEMENT (Filed With SEC on February 27, 2017)

NOVAVAX, INC. 2015 Stock Incentive Plan (Amended and Restated March 15, 2016) Incentive Stock Option Agreement (Performance-and Time-Based Vesting) (Filed With SEC on November 16, 2016)

THIRD AMENDMENT TO LEASE (Filed With SEC on May 5, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2016)

DEED OF LEASE TABLE OF CONTENTS (Filed With SEC on May 5, 2016)

W I T N E S S E T H: (Filed With SEC on February 29, 2016)

JPMorgan Chase Bank, National Association Organised under the laws of the United Statesas a National Banking Association. Main Office 1111 Polaris Parkway, Columbus,Ohio 43240... (Filed With SEC on February 29, 2016)

NOVAVAX, INC. $300,000,000 3.75% Convertible Notes due 2023 Purchase Agreement (Filed With SEC on January 29, 2016)

NOVAVAX, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee INDENTURE Dated as of January 29, 2016 3.75% Convertible Senior Notes due 2023 (Filed With SEC on January 29, 2016)

JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on January 29, 2016)

[**] = Portions of this exhibit have been omittedpursuant to a confidential treatment request. An unredacted version of this exhibit has beenfiled separately with the Commission.... (Filed With SEC on November 9, 2015)

[**] = Portions of this exhibit have been omittedpursuant to a confidential treatment request. An unredacted version of this exhibit has beenfiled separately with the Commission. (Filed With SEC on November 9, 2015)

[**] = Portions of this exhibit have beenomitted pursuant to a confidential treatment request. An unredacted version of this exhibit hasbeen filed separately with the Commission.... (Filed With SEC on September 8, 2015)

DEED OF LEASE TABLE OF CONTENTS (Filed With SEC on August 21, 2015)

FIRST AMENDMENT TO DEED OF LEASE (Filed With SEC on August 21, 2015)

NOVAVAX, INC. 2015 Stock Incentive Plan Non-Statutory Stock Option Agreement (Filed With SEC on August 10, 2015)

NOVAVAX, INC. 2015 Stock Incentive Plan Incentive Stock Option Agreement (Filed With SEC on August 10, 2015)

NOVAVAX, INC. 2015 Stock Incentive Plan Restricted Stock Agreement (Filed With SEC on August 10, 2015)

24,137,931 Shares of Common Stock par value $0.01 3,620,689 Option Shares Novavax, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 27, 2015)

NOVAVAX, INC. Non-Statutory Stock Option Agreement (Filed With SEC on February 27, 2015)

NOVAVAX, INC. Incentive Stock Option Agreement (Filed With SEC on February 27, 2015)

NovavaxRESTRICTED STOCK AGREEMENT (Filed With SEC on February 27, 2015)

AMENDMENT No 5 to MASTER SERVICES AGREEMENT (Filed With SEC on February 27, 2015)

25,000,000 Shares of Common Stock par value $0.01 3,750,000 Over-Allotment Shares Novavax, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 9, 2014)

AMENDMENT No 4 to MASTER SERVICES AGREEMENT (Filed With SEC on March 12, 2014)

AMENDMENT No 3 to MASTER SERVICES AGREEMENT (Filed With SEC on October 30, 2013)

27,693,000 Shares of Common Stock par value $0.01 4,153,950 Over-Allotment Shares Novavax, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 24, 2013)

NOVAVAX, INC. AMENDED AND RESTATED 2005 STOCK INCENTIVEPLAN Adopted by the Board of Directors February24, 2005; Approved by Stockholders, May 4, 2005 Amended by the Board of... (Filed With SEC on March 12, 2013)

AMENDMENT No 2 to MASTER SERVICES AGREEMENT (Filed With SEC on March 12, 2013)

EXHIBIT1.1 At MarketIssuance Sales Agreement (Filed With SEC on October 2, 2012)

RELEASE OF CLAIMS AND RESTRICTIVE COVENANTSAGREEMENT (Filed With SEC on March 14, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)

LEASE AGREEMENT (Filed With SEC on March 14, 2012)

SUBLEASE (Filed With SEC on March 14, 2012)

LEASE AGREEMENT (Filed With SEC on March 14, 2012)

Exhibit 10.1 (Filed With SEC on November 14, 2011)

AMENDMENT No 1 to MASTER SERVICES AGREEMENT (Filed With SEC on November 8, 2011)

NOVAVAX, INC. AMENDED AND RESTATED 2005 STOCK INCENTIVE PLAN [Amended and Restated as of June 15, 2011] (Filed With SEC on August 9, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2011)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on May 10, 2011)

Guidelines On Significant Corporate Governance Issues Effective January 1, 2011 (Filed With SEC on May 10, 2011)

THIRD AMENDMENT TO SUBLEASE AGREEMENT (Filed With SEC on March 28, 2011)

6,800,000 Shares and 1,020,000 Over-Allotment Shares (Filed With SEC on November 20, 2009)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on November 9, 2009)

At Market Issuance Sales Agreement (Filed With SEC on September 15, 2009)

SECOND AMENDMENT TO SUBLEASE AGREEMENT (Filed With SEC on August 10, 2009)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on August 10, 2009)

STOCK PURCHASE AGREEMENT (Filed With SEC on August 10, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2009)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 22, 2009)

SECOND AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 22, 2009)

STOCK PURCHASE AGREEMENT (Filed With SEC on May 11, 2009)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 11, 2009)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on May 11, 2009)

Amendment to 4.75% Senior Convertible Notes (Filed With SEC on April 29, 2009)

CONSULTING AGREEMENT (Filed With SEC on February 20, 2009)

At Market Issuance Sales Agreement (Filed With SEC on January 13, 2009)

NOVAVAX, INC. (Filed With SEC on January 5, 2009)

NOVAVAX, INC. AMENDED AND RESTATED 2005 STOCK INCENTIVE PLAN (Filed With SEC on January 5, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on October 16, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on October 8, 2008)

AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 8, 2008)

TERMINATION OF SUBLEASE (Filed With SEC on August 11, 2008)

LEASE AGREEMENT (Filed With SEC on August 11, 2008)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 11, 2008)

SECOND AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 11, 2008)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on July 30, 2008)

Subscription Agreement (Filed With SEC on July 30, 2008)

Investor Rights Agreement (Filed With SEC on July 30, 2008)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on February 25, 2008)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on February 25, 2008)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTEDMATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on February 25, 2008)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [ * * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on August 9, 2007)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on July 6, 2007)

Amendment to 4.75% Senior Convertible Notes (Filed With SEC on June 18, 2007)

CONSULTING AGREEMENT (Filed With SEC on May 10, 2007)

THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF ACONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH[* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 16, 2007)

SUBLEASE (Filed With SEC on December 13, 2006)

[Letterhead of Pharmelle, LLC] (Filed With SEC on November 14, 2006)

NOVAVAX, INC. (Filed With SEC on November 14, 2006)

AMENDMENT TO SUBLEASE BETWEEN NOVAVAX, INC. AND STERILOX TECHNOLOGIES INC. (Filed With SEC on November 14, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2006)

LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on August 14, 2006)

SUPPLY AGREEMENT (Filed With SEC on August 14, 2006)

SUBLEASE AGREEMENT (Filed With SEC on August 14, 2006)

THEREGISTRANT HAS APPLIED FOR CONFIDENTIAL TREATMENT OF CERTAINPROVISIONS OF THIS EXHIBIT WITHTHE SECURITIES AND EXCHANGE COMMISSION. THE CONFIDENTIAL PORTIONSOF THIS EXHIBIT ARE... (Filed With SEC on March 6, 2006)

THE REGISTRANT HAS APPLIED FOR CONFIDENTIAL TREATMENT OF CERTAIN PROVISIONS OF THIS EXHIBIT WITH THE SECURITIES AND EXCHANGE COMMISSION. THE CONFIDENTIAL PORTIONS OF THIS EXHIBIT... (Filed With SEC on March 6, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2005)

LEASE (Filed With SEC on August 9, 2005)

LEASE AGREEMENT BETWEEN LIBERTY PROPERTY LIMITED PARTNERSHIP Landlord AND NOVAVAX, INC. Tenant FOR Great Valley Corporate Center 508 Lapp Road, Malvern, Pennsylvania (Filed With SEC on August 9, 2004)

NOVAVAX, INC. 4,500,000 Shares of Common Stock (par value $0.01 per share) Underwriting Agreement New York, New YorkC.E. Unterberg, Towbin November 12, 2003350 Madison Avenue New... (Filed With SEC on November 18, 2003)

Termination Event Separation Pay By you for Good Reason Six months base salary attime of termination, paidin accordance with Novavaxpayroll.By you or the Company due to Change of... (Filed With SEC on November 12, 2003)

Part I. Financial Information (Filed With SEC on August 13, 2003)

SECURED PROMISSORY NOTE (Filed With SEC on March 28, 2003)

PLEDGE AGREEMENT (Filed With SEC on March 28, 2003)

SECURED PROMISSORY NOTE (Filed With SEC on March 28, 2003)

PLEDGE AGREEMENT (Filed With SEC on March 28, 2003)

GUARANTY OF ACCOUNT (Filed With SEC on March 28, 2003)

NOTE (Filed With SEC on March 28, 2003)

SECURITY AGREEMENT (Filed With SEC on March 28, 2003)

NOTE (Filed With SEC on March 28, 2003)

SECURITY AGREEMENT (Filed With SEC on March 28, 2003)

[Novavax Letterhead] (Filed With SEC on August 14, 2002)

RIGHTS AGREEMENT by and between NOVAVAX, INC. and EQUISERVE TRUST COMPANY, N.A., as Rights Agent Dated as of August 8, 2002 TABLE OF CONTENTS (Filed With SEC on August 9, 2002)

Employment Agreement- James R. Mirto (Filed With SEC on March 15, 2002)

Employment Agreement-Dennis Genge (Filed With SEC on March 15, 2002)

Agreement of Lease-W.M.Rickman Construction Co (Filed With SEC on March 15, 2002)

Lease Agreement- GPG Enterprises (Filed With SEC on March 15, 2002)

Lease Agreement (Filed With SEC on March 15, 2002)

Facility Reservation Agreement (Filed With SEC on March 15, 2002)

FIRST AMENDMENT TO THE COPROMOTION AGREEMENT (Filed With SEC on August 13, 2001)

SECOND AMENDMENT TO THE COPROMOTION AGREEMENT (Filed With SEC on August 13, 2001)

FIRST AMENDMENT TO THE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on August 13, 2001)

SECOND AMENDMENT TO THE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on August 13, 2001)

Category

Industry

Companies

Contracts

NOVAVAX INC Contracts & Agreements